Conditions by Social Costs

Conditions here are listed according to social costs, which are the estimated US dollar costs of the condition. In most cases, the source data refers to the USA or other industrialized nations.

Condition Cost ($) Data
1. Cardiovascular diseases 329.2 billion $329.2 billion with $199.5b direct, $30.9b morbidity, $98.8b mortality (NHLBI 2002)
2. Injury 259 billion estimated $260 billion (IOM)
3. Heart disease 213 billion $214.0 billion with $115.0b direct, $19.0b morbidity, $80.0b mortality (NHLBI 2002)
4. Alcoholism 184 billion $185 billion each year for alcoholism in the US (Mayo Clinic)
5. Occupational Injuries 120 billion more than $121 billion annually (CDC-OC)
6. Lung conditions 115.9 billion $115.9 billion with $65.4b direct, $23.8b morbidity, $26.7b mortality (NHLBI 2002)
7. Coronary heart disease 111.8 billion $111.8 billion with $58.2b direct, $8.4b morbidity, $45.b mortality (NHLBI 2002)
8. Digestive Diseases 106 billion $107 billion in the USA 1992 (Digestive diseases in the United States: Epidemiology and Impact – NIH Publication No. 94-1447, 1994)
9. Overweight 99.2 billion $99.2 billion total including direct $51.6 billion and indirect $47.6 billion (NIDDK)
10. Alzheimer's Disease 80 billion $80 to $100 billion in health care expenses and lost wages of both patients and their caregivers (NIA)
11. Stroke 49.4 billion $49.4 billion with $30.8b direct, $5.6b morbidity, $13.0b mortality (NHLBI 2002)
12. Hypertension 47.2 billion $47.2 billion with $34.4b direct, $6.7b morbidity, $6.1bb mortality (NHLBI 2002)
13. Obesity 32 billion $33 billion annually spent on weight-loss products and services (NIDDK)
14. Chronic Obstructive
       Pulmonary Disease
32.1 billion $32.1 billion with $18.0b direct, $6.8b morbidity, $7.3b mortality (NHLBI 2002)
15. Drug-resistant infectious
       agents
30 billion as high as $30 billion (NIAID)
16. Congestive Heart Failure 23.2 billion $23.2 billion with $21.4b direct, unavailable morbidity, $1.8b mortality (NHLBI 2002); $3.4 billion was paid by Medicare in 1995 (CDC-OC)
17. End-stage renal disease 22.8 billion $22.8 billion in public and private spending for ESRD program costs in the USA 2001 (United States Renal Data System 2003 Annual Data Report, 2003)
18. Allergies 17 billion $18 billion annually (NIAID)
19. Sexually Transmitted
    Diseases
17 billion approximately $17 billion including HIV (NIAID)
20. Osteoporosis 17 billion $17 billion in direct expenditure in the USA (National Osteoporosis Foundation, 2004)
21. Medical misadventure 17 billion $17 to $29 billion per year (Institute of Medicine report).
22. Urinary Incontinence 16.3 billion $16.3 billion in the USA 2001 (Obstetrics and Gynecology, 98:398-406, 2001)
23. Arthritis 15.2 billion $15.2 billion annually
24. Asthma 13 billion $14.0 billion with $9.4b direct, $2.7b morbidity, $1.9b mortality (NHLBI 2002)
25. Migraine 12 billion $13 billion in missed work or reduced productivity annually (NINDS)
26. Blood conditions 9.7 billion $9.7 billion with $7.1b direct, $0.7b morbidity, $1.9b mortality (NHLBI 2002)
27. Obsessive-compulsive
      disorder
8.4 billion $8.4 billion in 1990 in social and economic losses in the USA (NIMH)
28. Pelvic Inflammatory
      Disease
6 billion estimated $7 billion in 1997 (NIAID)
29. HIV/AIDS 6.7 billion approximately $6.7 billion in 1994 (NIAID)
30. Anemia 6.4 billion $6.4 billion with $4.9b direct, $0.6b morbidity, $0.9b mortality (NHLBI 2002)
31. Peptic Ulcer 5 billion $6 billion annually (DBMD)
32. Sinusitis 5.8 billion more than $5.8 billion in 1996 (NIAID)
33. Chronic Sinusitis 5.8 billion more than $5.8 billion in US health care expenditure (NIAID)
34. Food poisoning 5 billion $5 to $6 billion (NIAID)
35. Nosocomial infections 4.5 billion more than $4.5 billion in 1992 (CDC/NNIS 1992)
36. Human Papillomavirus 3.8 billion estimated $3.8 billion in 1994 (NIAID)
37. Heart failure 3.4 billion $3.4 billion in 1995 in the USA
38. Autism 2 billion more than $3 billion each year in health and educational services (NIMH)
39. Chlamydia 2 billion more than $2 billion
40. Urinary stones 1.8 billion $1.83 billion (direct and indirect) for evaluation and treatment in the USA 1993 (Journal of Urology, 1995)
41. Kidney stones 1.8 billion $1.83 billion was spent on indirectly and directly on the evaluation and treatment of kidney stones in the US 1993 (Weighted Analysis of 1999 NAMCS, 2003, NIDDK)
42. Gonorrhea 1.1 billion almost $1.1 billion (NIAID)
43. Rotavirus 1 billion more than $1 billion in total costs to society including $264 million direct costs (CDC-OC)
44. Chickenpox 918 million estimated $918 million in 1993
45. Cervical Cancer 736 million approximately $737 million
46. Hepatitis C 600 million $600 million (CDC-OC)
47. Group B Streptococcal
       Infections
293 million $294 million annually in direct medical costs of neonatal disease before prevention (DBMD)
48. Guillain-Barre Syndrome 247 million $247 million to $1.8 billion for Campylobacter induced GBS (NIAID)
49. Genital herpes 237 million approximately $237 million in 1994 (NIAID)
50. Hepatitis A 200 million $200 million in 1991 (CDC-OC)
51. Hepatitis B 156 million $156 million in 1994 (NIAID)
52. Syphilis 106 million estimated $106 million in 1994 (NIAID)
53. Lyme disease 60 million estimated $60 million a year (NIAID)
54. Japanese encephalitis 1 million less than $1 million annually (DVBID)



Chinese Translation

条件的社会成本

Conditions here are listed according to social costs, which are the estimated US dollar costs of the condition. In most cases,the source data refers to the USA or other industrialized nations.                                                                                                       

Condition 条件 Cost ($) 费用($) Data 数据
1. Cardiovascular diseases
1。 心血管疾病
329.2 billion 329200000000 $329.2 billion with $199.5b direct, $30.9b morbidity, $98.8b mortality (NHLBI 2002)
三千二百九十二点零亿美元美元199.5b直接,$ 30.9b发病率,死亡率$ 98.8b(全文2002)
2. Injury
2。 损伤
259 billion 2590.00亿 estimated $260 billion (IOM)
估计二千六百点零零亿美元(移徙组织)
3. Heart disease
3。 心脏病
213 billion 2130.000亿 $214.0 billion with $115.0b direct, $19.0b morbidity, $80.0b mortality (NHLBI 2002)
二百十四点零美元亿美元115.0b直接,$ 19.0b发病率,死亡率$ 80.0b(全文2002)
4. Alcoholism
4。 酒精中毒
184 billion 1840.0亿 $185 billion each year for alcoholism in the US (Mayo Clinic)
一千八百五十〇万点零零零万美元每年在美国酗酒(梅奥诊所)
5. Occupational Injuries
5。 职业伤害
120 billion 120000000000 more than $121 billion annually (CDC-OC)
超过了1210亿元左右(疾病预防控制中心,业主立案法团)
6. Lung conditions
6。 肺条件
115.9 billion 1159亿 $115.9 billion with $65.4b direct, $23.8b morbidity, $26.7b mortality (NHLBI 2002)
一千一百五十九万点零万美元直接65.4b美元,达到238亿美元的发病率,死亡率$ 26.7b(全文2002)
7. Coronary heart disease
7。 冠心病
111.8 billion 1118.0亿 $111.8 billion with $58.2b direct, $8.4b morbidity, $45.b mortality (NHLBI 2002)
一千一百十八万点零万美元美元58.2b直接,$ 8.4b发病率,死亡率$ 45.b(全文2002)
8. Digestive Diseases
8。 消化系统疾病
106 billion 1060.00亿 $107 billion in the USA 1992 (Digestive diseases in the United States: Epidemiology and Impact – NIH Publication No. 94-1447, 1994)
107美元 , 在美国1992亿美元(消化道疾病在美国:流行病学和影响- NIH出版物94-1447号,1994年)
9. Overweight
9。 超重
99.2 billion 992.0亿 $99.2 billion total including direct $51.6 billion and indirect $47.6 billion (NIDDK)
九百九十二点〇 〇 〇亿美元总额 , 包括直接五一六零零零零零零零零美元和间接四百七十六点〇 〇亿美元(NIDDK)
10. Alzheimer's Disease
10。 阿尔茨海默氏病
80 billion 80000000000 $80 to $100 billion in health care expenses and lost wages of both patients and their caregivers
(NIA)
80元至100亿美元的医疗费用和损失的病人和他们的护理人员(国家行政学院工资)
11. Stroke
11。 行程
49.4 billion 49400000000 $49.4 billion with $30.8b direct, $5.6b morbidity, $13.0b mortality (NHLBI 2002)
四百九十四点零零亿美元美元30.8b直接,$ 5.6b发病率,死亡率$ 13.0b(全文2002)
12. Hypertension
12。 高血压
47.2 billion 四百七十二点零零亿 $47.2 billion with $34.4b direct, $6.7b morbidity, $6.1bb mortality (NHLBI 2002)
四百七十二点零亿美元美元34.4b直接,$ 6.7b发病率,死亡率$ 6.1bb(全文2002)
13. Obesity
13。 肥胖
32 billion 320.00亿 $33 billion annually spent on weight-loss products and services (NIDDK) 每年330亿元用于对体重损耗的产品和服务(NIDDK)
14. Chronic Obstructive Pulmonary Disease
14。 慢性阻塞性肺病
32.1 billion 321.000亿 $32.1 billion with $18.0b direct, $6.8b morbidity, $7.3b mortality (NHLBI 2002) 三百二十一万点零零万美元美元18.0b直接,$ 6.8b发病率,死亡率$ 7.3b(全文2002)
15. Drug-resistant infectious agents 15。 耐药性传染性病原体 30 billion 300.00亿 as high as $30 billion (NIAID)
高达300亿美元(NIAID的)
16. Congestive Heart Failure
16。 充血性心力衰竭
23.2 billion 23200000000 $23.2 billion with $21.4b direct, unavailable morbidity, $1.8b mortality (NHLBI 2002); $3.4 billion was paid by Medicare in 1995 (CDC-OC)
二百三十二点零零零亿美元美元21.4b直接,不可用发病率,死亡率$突破18亿(全文2002年);三十四万点〇万美元支付1995年(疾病预防控制中心,由医疗保险业主立案法团)
17. End-stage renal disease
17。 终末期肾脏疾病
22.8 billion 22800000000 $22.8 billion in public and private spending for ESRD program costs in the USA 2001 (United States Renal Data System 2003 Annual Data Report, 2003)
二百二十八万点零零零万美元公营和私营机构在2001年美国(美国肾脏病数据系统2003年年度数据报告,2003年计划的费用支出终末期肾病)
18. Allergies
18。 过敏
17 billion 170.0亿 $18 billion annually (NIAID)
一百八十○万点零零零万美元每年研究所(NIAID)
19. Sexually Transmitted Diseases 19。 性传播疾病 17 billion 170.0亿 approximately $17 billion including HIV (NIAID)
约170亿美元 , 包括艾滋病毒研究所(NIAID)
20. Osteoporosis
20。 骨质疏松症
17 billion 170.0亿 $17 billion in direct expenditure in the USA (National Osteoporosis Foundation, 2004)
170亿美元在美国的直接开支(国家骨质疏松基金会,2004年)
21. Medical misadventure
21。 医疗事故
17 billion 170.0亿 $17 to $29 billion per year (Institute of Medicine report).
$ 17至$ 29每年10亿美元(研究所)的一份研究报告。
22. Urinary Incontinence
22。 尿失禁
16.3 billion 163.00亿 $16.3 billion in the USA 2001 (Obstetrics and Gynecology, 98:398-406, 2001)
 一百六十三万点零零万美元在美国2001年(妇科,98:398-406,2001)
23. Arthritis
23。 关节炎
15.2 billion 152.0亿 $15.2 billion annually
一五二〇 〇 〇 〇 〇 〇 〇 〇美元每年
24. Asthma
24。 哮喘
13 billion 一百三十亿 $14.0 billion with $9.4b direct, $2.7b morbidity, $1.9b mortality (NHLBI 2002)
$ 14.0亿美元9.4b直接,$ 2.7b发病率,死亡率$ 1.9b(全文2002)
25. Migraine
25。 偏头痛
12 billion 120.00亿 $13 billion in missed work or reduced productivity annually (NINDS) 130亿美元错过工作或生产率下降 , 每年(中风研究所)
26. Blood conditions
26。 血液条件
9.7 billion 9700000000 $9.7 billion with $7.1b direct, $0.7b morbidity, $1.9b mortality (NHLBI 2002)
九十七万点〇 〇 〇万美元直接7.1b美元,$ 0.7b发病率,死亡率$ 1.9b(全文2002)
27. Obsessive-compulsive disorder 27。 强迫症 8.4 billion 8400000000 $8.4 billion in 1990 in social and economic losses in the USA (NIMH) $ 8.4亿美元于1990年在美国(NIMH的社会和经济损失)
28. Pelvic Inflammatory Disease
28。 盆腔炎
6 billion 6000000000 estimated $7 billion in 1997 (NIAID)
估计为7000000000研究所(NIAID)
1997
29. HIV/AIDS
29。 艾滋病毒/艾滋病
6.7 billion 6700000000 approximately $6.7 billion in 1994 (NIAID)
约670一万九千九百四亿研究所(NIAID)
30. Anemia
30。 贫血
6.4 billion 640000.0万 $6.4 billion with $4.9b direct, $0.6b morbidity, $0.9b mortality (NHLBI 2002)
六十四万点零零万美元美元4.9b直接,$ 0.6b发病率,死亡率$ 0.9b(全文2002)
31. Peptic Ulcer
31。 消化性溃疡
5 billion 50.000亿 $6 billion annually (DBMD)
六十〇万点〇 〇万美元每年(DBMD)
32. Sinusitis
32。 鼻窦炎
5.8 billion 5800000000 more than $5.8 billion in 1996 (NIAID)
超过580 1996亿美元(NIAID的)
33. Chronic Sinusitis
33。 慢性鼻窦炎
5.8 billion 5800000000 more than $5.8 billion in US health care expenditure (NIAID)
超过580亿美元医疗开支研究所(NIAID)
34. Food poisoning
34。 食物中毒
5 billion 50.000亿 $5 to $6 billion (NIAID)
5.000,000,000美元至6,000,000美元研究所(NIAID)
35. Nosocomial infections
35。 院内感染
4.5 billion 4500000000 more than $4.5 billion in 1992 (CDC/NNIS 1992)
4,500,000,000元以上1992元(疾病预防控制中心/ NNIS 1992)
36. Human Papillomavirus
36。 人乳头瘤病毒
3.8 billion 3800000000 estimated $3.8 billion in 1994 (NIAID)
估计为380,000,000 - 1994(NIAID)
37. Heart failure
37。 心力衰竭
3.4 billion 3400000000 $3.4 billion in 1995 in the USA
为3,400,000,000美元,1995年美国
38. Autism
38。 自闭症
2 billion 二十亿 more than $3 billion each year in health and educational services (NIMH) 超过3,000,000,000美元 , 每年在健康和(镍氢教育服务)
39. Chlamydia
39。 衣原体
2 billion 二十亿 more than $2 billion
更超过20亿美元
40. Urinary stones
40。 泌尿系结石
1.8 billion 18.0亿 $1.83 billion (direct and indirect) for evaluation and treatment in the USA 1993 (Journal of Urology, 1995)
十八点三亿美元(直接和间接评价和1993年在美国治疗)(泌尿科,1995年日报)
41. Kidney stones
41。 肾结石
1.8 billion 18.0亿 $1.83 billion was spent on indirectly and directly on the evaluation and treatment of kidney stones in the US 1993 (Weighted Analysis of 1999 NAMCS, 2003, NIDDK)
十八点三亿美元用在间接和直接的评价和1993年在美国治疗的肾结石(加权分析1999年NAMCS,2003年,NIDDK)
42. Gonorrhea
42。 淋病
1.1 billion 一十一亿 almost $1.1 billion (NIAID)
近11亿美元(NIAID的)
43. Rotavirus
43。 轮状病毒
1 billion 10.000亿 more than $1 billion in total costs to society including $264 million direct costs (CDC-OC)
逾1,000,000,000美元 , 在总成本亿社会 , 包括二万六千四百点零零万美元直接成本中心(CDC -业主立案法团)
44. Chickenpox
44。 水痘
918 million 9.180亿 estimated $918 million in 1993
估计九一八零零零零零零美元1993年
45. Cervical Cancer
45。 宫颈癌
736 million 736000000 approximately $737 million
 大约七点三七亿美元
46. Hepatitis C
46。 丙型肝炎
600 million 600000000 $600 million (CDC-OC) 6亿美元(疾病预防控制中心,业主立案法团)
47. Group B Streptococcal Infections 47。B组链球菌感染 293 million 2.93亿美元 $294 million annually in direct medical costs of neonatal disease before prevention (DBMD) 2.94亿美元的新生儿疾病直接医疗费用每年都要预防(DBMD)
48. Guillain-Barre Syndrome
48。 格林巴利综合征
247 million 2.470亿 $247 million to $1.8 billion for Campylobacter induced GBS (NIAID) 2.47亿美元18亿美元弯曲杆菌引起的金紫荆星章研究所(NIAID)
49. Genital herpes
49。 生殖器疱疹
237 million 23700.0万 approximately $237 million in 1994 (NIAID) 大约237美元在1994万美元(NIAID的)
50. Hepatitis A
50。 甲型肝炎
200 million 200000000 $200 million in 1991 (CDC-OC) $ 200 1991
亿美元(疾病预防控制中心,业主立案法团)
51. Hepatitis B
51。 乙型肝炎
156 million 1.56亿 $156 million in 1994 (NIAID)
156元1994万美元(NIAID的)
52. Syphilis
52。 梅毒
106 million 106000000 estimated $106 million in 1994 (NIAID)
估计为106 19.94亿研究所(NIAID)
53. Lyme disease
53。 莱姆病
60 million 60000000 estimated $60 million a year (NIAID)
大约6000万美元 , 每年研究所(NIAID)
54. Japanese encephalitis
54。 日本脑炎
1 million 100.00万 less than $1 million annually (DVBID)
少于每年100万美元(DVBID)


SelectionFile type iconFile nameDescriptionSizeRevisionTimeUser
Comments